Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians

被引:28
作者
Chakraborty, Anurupa [1 ]
Mishra, Ashwani K. [1 ]
Soni, Abha [1 ]
Regina, Thodum [1 ]
Mohil, R. [2 ]
Bhatnagar, D. [2 ]
Bhatnagar, A. [2 ]
Chintamani, Chintamani [2 ]
Sharma, P. C. [3 ]
Saxena, Sunita [1 ]
机构
[1] Inst Pathol, New Delhi 110029, India
[2] Safdarjang Hosp, New Delhi 110029, India
[3] Guru Gobind Singh Indraprastha Univ, Delhi, India
来源
CANCER DETECTION AND PREVENTION | 2009年 / 32卷 / 5-6期
关键词
Vitamin D receptor gene (VDR); 3 '-Untranslated region; Polymorphism; Genotype; Odds ratio; Link-age disequilibrium; Haplotype; Breast cancer; North Indian population; BINDING-PROTEIN; CELL-PROLIFERATION; HIGH PREVALENCE; UNITED-STATES; D DEFICIENCY; ASSOCIATION; D-3; POPULATION; WOMEN; VARIANTS;
D O I
10.1016/j.canep.2009.04.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Vitamin D (1,25-dihydroxyVitamin D-3) has shown experimentally anticarcinogenic effects and is thought to protect against breast cancer. The actions of Vitamin D are mediated via the Vitamin D receptor (VDR), and the polymorphisms at 3'UTR region of this gene are associated with the risk and progression of breast carcinoma. The current study is an attempt to examine the association of these variations with breast cancer risk in north Indians. Methods: A total of 160 cases and 140 control subjects were studied for the polymorphisms at 3' end of the VDR gene. A polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) method and fragment analysis was performed to determine Apal and Taql polymorphisms and variable length poly-A microsatellite repeats. Linkage disequilibrium (LD) was calculated for each pair of polymorphisms. Unadjusted and adjusted odds ratios for breast cancer with genotypes comprising the polymorphic sites were calculated to understand their role towards breast cancer susceptibility. Results: Patient's with long poly-A repeat showed a significant association with disease (chi(2) = 9.52, df = 2, P <= 0.01). Compared to subjects having two S alleles (SS), odds ratios (and 95% CI) were 0.75 (0.45-1.23) and 2.49 (1.18-5.27) for subjects having genotypes SL and LL, respectively. Among matched pairs (age), the poly-A LL genotype was found significantly associated with increased risk of breast cancer among early-onset cases (P = 0.02). The unconditional logistic regression analysis demonstrated a significant association between grade and LL genotype [(unadjusted odds ratio (95% CI): 4.45 (1.87, 10.63); adjusted odds ratio: 4.66 (1.88, 11.53)]. No significant association was observed for the VDR Apal (chi(2) = 1.00, df = 2, P = 0.60) and TaqI polymorphism(chi(2) = 0.35, df = 2, P = 0.83). Although, strong LID was not observed among these polymorphic sites, it denies the total equilibrium at the same time. Based on haplotype distribution, the most common one observed among cases and controls was ATS while, genotype AATTLL had shown a significant association with the breast cancer risk (P = 0.02). Conclusions: The results indicate that the VDR poly-A polymorphism is significantly associated with breast cancer risk in north Indians especially with early onset disease. Although, Apal and TaqI did not show any significant association with the disease when analyzed in isolation, but Taql might modulate the risk associated with L alleles. Further, understanding the functional role of these variants residing on the VDR haplotype associated with disease susceptibility may suggest novel approaches for breast cancer prevention and therapy. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:386 / 394
页数:9
相关论文
共 42 条
[1]   Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk [J].
Abbas, Sascha ;
Nieters, Alexandra ;
Linseisen, Jakob ;
Slanger, Tracy ;
Kropp, Silke ;
Mutschelknauss, Elke Jonny ;
Flesch-Janys, Dieter ;
Chang-Claude, Jenny .
BREAST CANCER RESEARCH, 2008, 10 (02)
[2]  
[Anonymous], 2002, IARC PUBL
[3]   The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene [J].
Arai, H ;
Miyamoto, KI ;
Yoshida, M ;
Yamamoto, H ;
Taketani, Y ;
Morita, K ;
Kubota, M ;
Yoshida, S ;
Ikeda, M ;
Watabe, F ;
Kanemasa, Y ;
Takeda, E .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (07) :1256-1264
[4]   Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population [J].
Bretherton-Watt, D ;
Given-Wilson, R ;
Mansi, JL ;
Thomas, V ;
Carter, N ;
Colston, KW .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :171-175
[5]   Vitamin D receptor gene polymorphisms in breast cancer [J].
Buyru, N ;
Tezol, A ;
Yosunkaya-Fenerci, E ;
Dalay, N .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2003, 35 (06) :550-555
[6]  
COLSTON KW, 1989, LANCET, V1, P188
[7]   Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer [J].
Colston, KW ;
Hansen, CM .
ENDOCRINE-RELATED CANCER, 2002, 9 (01) :45-59
[8]   EFFECTS OF SYNTHETIC VITAMIN-D ANALOGS ON BREAST-CANCER CELL-PROLIFERATION INVIVO AND INVITRO [J].
COLSTON, KW ;
CHANDER, SK ;
MACKAY, AG ;
COOMBES, RC .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (04) :693-702
[9]  
Curran JE, 1999, INT J CANCER, V83, P723, DOI 10.1002/(SICI)1097-0215(19991210)83:6<723::AID-IJC4>3.0.CO
[10]  
2-3